[
  {
    "date": "2023-12-30",
    "symbol": "LEGN",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-39307",
    "entityregistrantname": "LEGEND BIOTECH CORPORATION",
    "entityaddresscountry": "KY",
    "entityaddressaddressline1": "Legend Biotech Corporation",
    "entityaddressaddressline2": "2101 Cottontail Lane",
    "entityaddresscityortown": "Somerset",
    "entityaddressstateorprovince": "NJ",
    "entityaddresspostalzipcode": 8873,
    "contactpersonnelname": "Ying Huang",
    "cityareacode": 737,
    "localphonenumber": "317-5050",
    "security12btitle": "American depositary shares, each representing two ordinary shares, par value $0.0001 per share",
    "tradingsymbol": "LEGN",
    "securityexchangename": "NASDAQ",
    "entitycommonstocksharesoutstanding": 363822069,
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "icfrauditorattestationflag": "true",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "documentfiscalyearfocus": 2023,
    "entitycentralindexkey": 1801198,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "entityincorporationstatecountrycode": "E9",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Iselin, New Jersey",
    "revenuefromlicensingofintellectualproperty": 35160000,
    "collaborationrevenue": 249804000,
    "otherrevenue": 179000,
    "revenue": 285143000,
    "costofsales": 144214000,
    "otherincomeandgains": 58126000,
    "researchanddevelopmentexpense": 382218000,
    "administrativeexpense": 106769000,
    "sellinganddistributionexpenses": 94158000,
    "otherexpensebynature": 28484000,
    "fairvaluelossofwarrantsliabilities": 85750000,
    "financecosts": 21794000,
    "profitlossbeforetax": -520118000,
    "incometaxexpensecontinuingoperations": -1864000,
    "profitloss": -518254000,
    "profitlossattributabletoownersofparent": -518254000,
    "basicearningslosspershare": -1.47,
    "dilutedearningslosspershare": -1.47,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 29633000,
    "othercomprehensiveincomethatwillbereclassifiedtoprofitorlossnetoftax": 29633000,
    "othercomprehensiveincome": 29633000,
    "comprehensiveincome": -488621000,
    "comprehensiveincomeattributabletoownersofparent": -488621000,
    "propertyplantandequipment": 108725000,
    "advancepaymentsforpropertyplantandequipment": 451000,
    "rightofuseassets": 80502000,
    "timesdepositsnoncurrent": 4362000,
    "intangibleassetsotherthangoodwill": 4061000,
    "collaborationprepaidleases": 151216000,
    "othernoncurrentnonfinancialassets": 1493000,
    "noncurrentassets": 350810000,
    "inventories": 19433000,
    "currenttradereceivables": 100041000,
    "currentprepaymentsandothercurrentassets": 69251000,
    "currentfinancialassetsatfairvaluethroughprofitorloss": 663000,
    "pledgeddeposits": 357000,
    "timesdeposits": 30341000,
    "cashandcashequivalents": 1277713000,
    "currentassets": 1497799000,
    "assets": 1848609000,
    "tradeandotherpayablestotradesuppliers": 20160000,
    "otherpayablesandaccrualscurrent": 132802000,
    "currentgovernmentgrants": 68000,
    "currentleaseliabilities": 3175000,
    "currenttaxliabilities": 7203000,
    "currentcontractliabilities": 53010000,
    "currentliabilities": 216418000,
    "longtermborrowings": 281328000,
    "noncurrentleaseliabilities": 44169000,
    "noncurrentgovernmentgrants": 7305000,
    "noncurrentcontractliabilities": 47962000,
    "othernoncurrentliabilities": 56000,
    "noncurrentliabilities": 380820000,
    "liabilities": 597238000,
    "issuedcapital": 36000,
    "otherreserves": 1251335000,
    "equityattributabletoownersofparent": 1251371000,
    "equity": 1251371000,
    "equityandliabilities": 1848609000,
    "issueofequity": 1000,
    "increasedecreasethroughexerciseofoptions": 18051000,
    "increasedecreasethroughreclassificationofvestedrestrictedstockequity": 25878000,
    "increasedecreasethroughsharebasedpaymenttransactions": 47680000,
    "adjustmentsforfinanceincome": 54487000,
    "adjustmentsforfinancecosts": 21794000,
    "adjustmentsforinventoryreserveprovision": 3627000,
    "adjustmentsfordepreciationexpense": 10704000,
    "gainslossesondisposalsofpropertyplantandequipment": -226000,
    "adjustmentsforamortisationexpense": 1924000,
    "adjustmentsfordepreciationofrightofuseassets": 7823000,
    "adjustmentforfairvaluelossgainofwarrantliability": 85750000,
    "adjustmentsforfairvaluegainslosses": -663000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 28224000,
    "expensefromsharebasedpaymenttransactionswithemployees": 47680000,
    "deferredgovernmentgrant": -628000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -368144000,
    "adjustmentsfordecreaseincreaseintradeaccountreceivable": -98980000,
    "adjustmentsfordecreaseincreaseinprepaymentsotherreceivableotherassets": -8724000,
    "adjustmentsfordecreaseincreaseinothernoncurrentassets": 753000,
    "adjustmentsfordecreaseincreaseininventories": -12706000,
    "adjustmentsforgovernmentgrantreceived": 23000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -12702000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": -38809000,
    "adjustmentsforincreasedecreaseinothernoncurrentliabilities": -176000,
    "adjustmentsforincreasedecreaseincontractliabilitiescurrent": 52500000,
    "adjustmentsforincreasedecreaseincontractliabilitiesnoncurrent": 47500000,
    "cashflowsfromusedinoperations": -439465000,
    "incometaxespaidclassifiedasoperatingactivities": 668000,
    "financeincomereceivedclassifiedasoperatingactivities": 47275000,
    "incometaxespaidrefundclassifiedasoperatingactivities": -976000,
    "interestonleasepaymentsclassifiedasoperatingactivities": -1394000,
    "cashflowsfromusedinoperatingactivities": -393276000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 20084000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 2638000,
    "prepaymenttocollaboratorforcollaborationrightofuseassets": 98784000,
    "cashreceivedfromwithdrawaloffinancialassetsatfairvaluethroughprofitorloss": 185000000,
    "cashreceiptsofinvestmentincomeclassifiedasinvestingactivities": 8810000,
    "additionintimedeposits": 4863149000,
    "decreaseintimedeposits": 4882724000,
    "decreaseinpledgeddeposits": 907000,
    "cashflowsfromusedininvestingactivities": 92786000,
    "proceedsfromissuanceofordinarysharesforinstitutionalinvestorsnetofissuancecost": 234410000,
    "proceedsfromissuanceofordinarysharesforfollowonpublicofferingnetofissuancecosts": 349278000,
    "proceedsfromexerciseofwarrantbywarrantholdernetofissuancecost": 199741000,
    "proceedsfromexerciseofoptions": 11816000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 3755000,
    "cashflowsfromusedinfinancingactivities": 791490000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 491000000,
    "effectofexchangeratechangesoncashandcashequivalents": 682000,
    "cash": 1312773000,
    "shorttermdepositsclassifiedascashequivalents": 357000,
    "timesdepositscurrentandnoncurrent": 34703000,
    "cashandcashequivalentsasstatedinstatementoffinancialposition": 1277713000,
    "cashandcashequivalentsasstatedinstatementofcashflows": 1277713000,
    "disclosureofnotesandotherexplanatoryinformationexplanatory": "CORPORATE INFORMATION",
    "disclosureofsummaryofsignificantaccountingpoliciesexplanatory": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
    "disclosureofrevenueotherincomeandgainsexplanatorytextblock": "REVENUE, OTHER INCOME AND GAINS",
    "entiredisclosureoffinancecostsexplanatorytextblock": "FINANCE COSTS",
    "disclosureofprepaymentsotherreceivablesandotherassetsexplanatorytextblock": "PREPAYMENTS, OTHER RECEIVABLES AND OTHER ASSETS",
    "disclosureofotherpayablesandaccrualsexplanatorytextblock": "OTHER PAYABLES AND ACCRUALS",
    "disclosureofwarrantliabilityexplanatorytextblock": "WARRANT LIABILITY",
    "restrictedstockunitsexplanatorytextblock": "RESTRICTED SHARE UNITS",
    "descriptionofaccountingpolicyforinvestmentsandotherfinancialassetsexplanatorypolicytextblock": "Investments and other financial assetsInitial recognition and measurementFinancial assets are classified, at initial recognition, as subsequently measured at amortized cost, and fair value through profit or loss.The classification of financial assets at initial recognition depends on the financial asset’s contractual cash flow characteristics and the Company’s business model for managing them. With the exception of trade receivables that do not",
    "timedepositspolicytextblock": "Time depositsTime deposits represent cash placed with banks with original maturities of more than three months when acquired. The time deposits are presented as a non-current asset if the collection of time deposits is expected more than one year.",
    "disclosureofintangibleassetsamortizationexplanatorytabletextblock": "Intangible assets are amortized on the straight-line basis over the following useful economic lives:Software3 yearsPatentsup to 20 years",
    "disclosureofestimatedusefullivesofrightofuseassetsexplanatorytabletextblock": "Right-of-use assets are depreciated on a straight-line basis over the shorter of the lease terms and the estimated useful lives of the assets as follow;",
    "disclosureofnoncurrentassetinformationtextblock": "Non-current assets",
    "disclosureofdeferredrevenuefromcustomercontractliabilitiestextblock": "The following table shows the deferred revenue which is included in contract liabilities for the periods presented:20232022US$’000US$’000Contract liabilities (Current)53,010 — Contract liabilities (Non Current)47,962 — Total 100,972 —",
    "disclosureofprofitlossbeforetaxarrivedafterchargingtabletextblock": "The Company’s loss before tax is arrived at after charging:202320222021US$’000US$’000US$’000Employee benefit expense (including directors’ remuneration):Wages and salaries204,128 147,385 105,751 Other employee benefits7,729 5,057 2,257 Equity-settled share-based compensation expense47,680 34,338 20,158",
    "detaileddisclosureoftaxchargestabletextblock": "Taxes on profits assessable elsewhere have been calculated at the rates of tax prevailing in the jurisdictions in which the Group operates.202320222021US$’000US$’000US$’000Current – United States of America511 224 211 Current – Elsewhere(2,375)401 416 Deferred (note 20)— — (4,241)Total tax charge/(credit) for the year(1,864)625 (3,614)",
    "disclosureofothernoncurrentassetstabletextblock": "December 31,2023December 31,2022US$’000US$’000Prepaid expenses1,208 1,092 Lease receivables285 395 Total 1,493 1,487",
    "lesseeleaseexpensestextblock": "The amounts recognized in profit or loss in relation to leases are as follows:",
    "disclosureofdetailedinformationaboutinventoriesexplanatorytabletextblock": "December 31,2023December 31,2022US$’000US$’000Raw materials13,155 6,989 Work-in-process2,990 690 Finished goods3,288 2,675 Total collaboration inventories19,433 10,354",
    "disclosureofdetailedinformationoftradereceivablestabletextblock": "December 31,2023December 31,2022US$’000US$’000Trade receivables100,041 90",
    "disclosureofdetailedinformationaboutprepaymentsotherreceivablesandotherassetsexplanatorytabletextblock": "December 31,2023December 31,2022US$’000US$’000Other Collaboration Receivables*54,078 40,376 Interest receivable47 1,517 Other receivables*790 948 Lease receivables1,388 188 VAT recoverable717 1,396 Prepayments*12,231 17,330 Total 69,251 61,755 *Certain prior year amounts have been reclassified for comparative purposes",
    "disclosureofdetailedinformationaboutcashandcashequivalentstimedepositsandpledgeddepositsexplanatorytabletextblock": "December 31,2023December 31,2022US$’000US$’000Cash and bank balances1,312,773 841,317 Less: Pledged deposits(357)(1,270)Time deposits(34,703)(54,016)Cash and cash equivalents1,277,713 786,031 Denominated in USD1,254,969 727,160 Denominated in RMB12,675 21,472 Denominated in EUR10,069 37,399 Cash and cash equivalents1,277,713 786,031",
    "disclosureoftradeandotherpayablestabletextblock": "December 31,2023December 31,2022US$’000US$’000Trade payables20,160 32,893",
    "disclosureofdetailedinformationaboutotherpayablesandaccrualsexplanatorytabletextblock": "December 31,2023December 31,2022US$’000US$’000Accrued payroll30,974 21,892 Accrued expense71,462 127,390 Other payables11,944 10,960 Payable for Collaboration Assets 16,338 22,852 Other tax payables2,084 1,015 132,802 184,109",
    "disclosureofdetailedinformationaboutdeferredtaxassetsexplanatorytabletextblock": "Deferred tax assets have not been recognized in respect of the following items as of the end of the reporting year:20232022US$’000US$’000Deductible temporary differences440,801 210,953 Tax losses and credits1,241,550 1,002,104 Total 1,682,351 1,213,057",
    "disclosureofdetailedinformationaboutwarrantliabilityexplanatorytabletextblock": "The movement of the warrant liability is set out as below:20232022US$’000US$’000Balance, beginning of the period67,000 87,900 Fair value loss/(gain) of the warrant liability85,750 (20,900)Exercise of the warrant liability(152,750)— Balance, end of the period— 67,000",
    "disclosureofdeferredgovernmentgrantsexplanatorytabletextblock": "20232022US$’000US$’000Deferred government grants7,373 8,110 Current68 451 Non-current7,305 7,659",
    "disclosureoftotalcashoutflowforleasesincludedinstatementofcashflowsexplanatorytabletextblock": "The total cash outflow for leases included in the statement of cash flows is as follows:202320222021US$’000US$’000US$’000Within operating activities1,394 527 142 Within financing activities3,755 2,596 1,419 Short-term leases2,338 1,132 182 Total 7,487 4,255 1,743",
    "disclosureofcapitalcommitmentsexplanatorytabletextblock": "The Company had the following capital commitments at the end of the year:202320222021US$’000US$’000US$’000Construction in progress11,270 22,706 25,897",
    "disclosureofamountsincurredforcompensationofkeymanagementpersonnelexplanatorytabletextblock": "Compensation of key management personnel of the Company:",
    "disclosureofinformationofinputsusedinfairvaluevaluationofwarrantliabilityexplanatorytabletextblock": "The following table lists the inputs to the binominal model used for the fair value valuation of warrant liability:December 31, 2022Underlying stock price$24.96 Volatility62.3 %Risk free rate3.8%-4.7%Dividend0 %",
    "disclosureofdetailedinformationaboutmonitoringcapitalusinggearingratioexplanatorytabletextblock": "The Company monitors capital using a gearing ratio, which is total liabilities divided by total assets. The gearing ratios as at the end of each year were as follows:December 31,2023December 31,2022US$’000US$’000Total liabilities597,238 586,651 Total assets1,848,609 1,330,963 Gearing ratio32 %44 %",
    "nameofsubsidiary": "Legend Biotech Limited (“Legend BVI”)",
    "placeanddateofincorporationofbusinessofsubsidiary": "The British Virgin Islands June 2, 2015",
    "proportionofownershipinterestinsubsidiary": 1,
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Investment holding",
    "futureestimatedmilestonepayments": 1020000000,
    "milestonepaymentnoteligibletoreceivebasedonsubsequentchangeindevelopmentplan": 280000000,
    "collaborationagreementnumberofcustomers": 1,
    "transactionprice": 120710000,
    "proceedsfrommilestonepayments": 35000000,
    "numberofmilestonepayments": 2,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P39Y",
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P3Y",
    "leasetermsandestimatedusefullivesofrightofuseassets": "P50Y",
    "revenuefromcontractswithcustomers": 35160000,
    "noncurrentassetsotherthanfinancialinstrumentsdeferredtaxassetspostemploymentbenefitassetsandrightsarisingunderinsurancecontracts": 151225000,
    "performanceobligationsatisfactionperiod": "P4Y",
    "contractliabilities": 100972000,
    "transactionpriceallocatedtoremainingperformanceobligations": 125310000,
    "financeincome": 54487000,
    "governmentgrantsreceivedfromlocalgovernmentauthorities": 2731000,
    "otherfinanceincome": 245000,
    "otherincome": 57463000,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": 663000,
    "othergainslosses": 663000,
    "wagesandsalaries": 204128000,
    "otheremployeeexpense": 7729000,
    "interestexpenseonleaseliabilities": 1394000,
    "interestexpenseonborrowings": 20400000,
    "accountingprofit": 2000000,
    "applicabletaxrate": 0.0825,
    "applicabletaxrateonremainingassessableprofits": 0.165,
    "withholdingtaxrate": 0.3,
    "nontradingincometaxrate": 0.25,
    "currenttaxrelatingtoitemschargedorcrediteddirectlytoequity": 511000,
    "currentanddeferredtaxrelatingtoitemschargedorcrediteddirectlytoequity": -1864000,
    "taxexpenseincomeatstatutoryblendedincometaxrate": -126638000,
    "taxeffectofforeignpreferentialtaxrates": 4091000,
    "taxeffectofforeigntaxrates": 47001000,
    "taxeffectsresearchanddevelopmentcredit": -8942000,
    "taxeffectfromchangeintaxrate": 5959000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 2111000,
    "taxlossesanddeductibletemporarydifferencesnotrecognized": 83054000,
    "taxeffectofoptionincometaxexpensebenefit": -7911000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": -589000,
    "statutoryblendedincometaxrate": 0.243,
    "taxrateeffectofforeignpreferentialtaxrates": -0.008,
    "taxrateeffectofforeigntaxrates": -0.09,
    "taxrateeffectonresearchanddevelopmentcredit": 0.017,
    "taxrateeffectfromchangeintaxrate": -0.011,
    "taxrateeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": -0.004,
    "taxrateeffectoftaxlosses": -0.16,
    "taxrateeffectofoptionincometaxbenefit": 0.015,
    "othertaxrateeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": 0.002,
    "averageeffectivetaxrate": 0.004,
    "weightedaverageshares": 352165418,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 238000,
    "disposalspropertyplantandequipment": 87000,
    "depreciationpropertyplantandequipment": 1493000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -116000,
    "increasedecreasethroughtransfersfromtoinvestmentpropertypropertyplantandequipment": 20344000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 2638000,
    "disposalsintangibleassetsotherthangoodwill": 61000,
    "amortisationintangibleassetsotherthangoodwill": 1924000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": -1000,
    "prepayments": 1208000,
    "financeleasereceivables": 285000,
    "othernoncurrentassets": 1493000,
    "lesseeleasingarrangementsleasesterm": "P3Y",
    "additionstorightofuseassets": 880000,
    "increasedecreasethrougheffectofexchangerealignmentinforeignexchangerate": -72000,
    "depreciationrightofuseassets": 93000,
    "leaseliabilities": 47344000,
    "increaseinleaseliabilities": 26692000,
    "increaseofleaseliabilitiesbalance": 1394000,
    "cashoutflowforleases": 5149000,
    "increasedecreasethrougheffectofchangesinforeignexchangeratesliabilitiesarisingfromfinancingactivities": 805000,
    "expenserelatingtoshorttermleasesforwhichrecognitionexemptionhasbeenused": 2338000,
    "leaseexpenseamountrecognizedinprofitorloss": 11555000,
    "undiscountedfinanceleasepaymentstobereceived": 1673000,
    "rawmaterials": 13155000,
    "workinprogress": 2990000,
    "finishedgoods": 3288000,
    "inventoryreserve": 8900000,
    "creditperiodoftradereceivables": "P45D",
    "riskexposureassociatedwithinstrumentssharingcharacteristic": 100000000,
    "othercollaborationreceivables": 54078000,
    "interestreceivable": 47000,
    "otherreceivables": 790000,
    "valueaddedtaxreceivables": 717000,
    "prepaymentsotherreceivablesandotherassets": 69251000,
    "amountsreceivablerelatedpartytransactions": 40000,
    "cashandbankbalancesatcentralbanks": 1312773000,
    "pledgedshorttermdeposits": -357000,
    "depositsfrombank": -34703000,
    "tradepayablesterm": "P30D",
    "accruedpayroll": 30974000,
    "accruedexpense": 71462000,
    "otherpayables": 11944000,
    "payableforcollaborationassets": 16338000,
    "othertaxpayables": 2084000,
    "tradeandotherpayablestorelatedparties": 900000,
    "deferredtaxliabilities": 3144000,
    "deferredtaxexpenseincomerecognisedinprofitorlossrelatedtodeferredtaxliabilities": -3144000,
    "deferredtaxassets": 1521000,
    "deferredtaxexpenseincomerecognisedinprofitorlossrelatedtodeferredtaxassets": 1521000,
    "deferredtaxexpenseincome": -400000,
    "deferredtaxcarrybackperiod": "P1Y",
    "withholdingtaxpercentage": 0.1,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 440801000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 1241550000,
    "deferredtaxassetnotyetrecognized": 1682351000,
    "numberofsharesissued": 6366538,
    "parvaluepershare": 0.0001,
    "warrantliabilityfairvaluelossgainrecorded": 85800000,
    "exerciseofthewarrantliability": 152750000,
    "governmentgrants": 7373000,
    "borrowingsinterestrate": 0.0807,
    "noncurrentportionofnoncurrentloansreceived": 281328000,
    "borrowings": 250000000,
    "interestbearingborrowingsfundedinterestsaccrued": 31300000,
    "borrowingsadjustmenttointerestratebasis": 0.025,
    "numberofsharesauthorised": 2000000000,
    "authorizedsharecapital": 200000,
    "numberofsharesissuedandfullypaid": 363822069,
    "sharecapitalandsharepremiumnumberofsharesinissue": 363822069,
    "sharecapitalandsharepremium": 36000,
    "issuanceofordinarysharesrelatingtoprivateplacementforinstitutionalinvestornumberofsharesissue": 8834742,
    "issuanceofordinarysharerelatingtoprivateplacementforinstitutionalinvestor": 1000,
    "issuanceofordinarysharesforregistereddirectofferingnetofissuancecostnumberofsharesinissue": 10937500,
    "issuanceofordinarysharesforregistereddirectofferingnetofissuance": 1000,
    "issuanceofordinarysharesforexerciseofwarrantsshares": 10000000,
    "issuanceofordinarysharesforexerciseofwarrants": 1000,
    "exerciseofshareoptionnumberofsharesinissue": 2460172,
    "exerciseofshareoption": 18051000,
    "reclassificationofvestedrestrictedstockunitsnumberofsharesinissue": 1455175,
    "reclassificationofvestedrestrictedstockunitssharecapitalandsharepremium": 25878000,
    "weightedaverageexercisepriceofshareoptionsinsharebasedpaymentarrangementexercisedduringperiodatdateofexercise2019": 31.814,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 4800000,
    "weightedaveragesharepriceshareoptionsgranted2019": 13.397,
    "expensesrecognizedforshareoptions": 11300000,
    "weightedaveragesharepriceusedinshareoptionfairvalue": 23.53,
    "numberofoutstandingshareoptions": 6367000,
    "additionalsharecapitalamount": 637,
    "sharepremiumbeforeissueexpenses": 59400000,
    "percentageofoutstandingshareoptions": 0.017,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 9.3287,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 23.53,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 2.8336,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 5.0687,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 4.5401,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 355000,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 708000,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 2460000,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 3470000,
    "exercisepriceofoutstandingshareoptions2019": 0.5,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.661,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.034,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P10Y",
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement2019": 26.0613,
    "weightedaverageexercisepriceofotherequityinstrumentsgrantedinsharebasedpaymentarrangement2019": 29.604,
    "weightedaverageexercisepriceofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement2019": 17.7836,
    "weightedaverageexercisepriceofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement2019": 21.5612,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 4949000,
    "numberofinstrumentsotherequityinstrumentsgranted": 3429000,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 1455000,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 411000,
    "weightedaveragefairvalueatmeasurementdateotherequityinstrumentsgranted": 101500000,
    "percentageofnumberofnumbersharesissued": 0.014,
    "paidincapitalandreservefunds": 107300000,
    "noncashadditionstorightofuseassets": 26700000,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 26700000,
    "assetsleasedfromcollaborationpartner": 16300000,
    "noncashadditionstopropertyplantandequipment": 6600000,
    "liabilitiesarisingfromfinancingactivities": 47344000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -3755000,
    "interestpaidclassifiedasoperatingactivities": 1394000,
    "cashoutflowforleaseswithinoperatingactivities": 1394000,
    "cashoutflowforleaseswithinfinancingactivities": 3755000,
    "cashoutflowforshorttermleases": 2338000,
    "constructionpaymentpayableinfuture": 11270000,
    "areaofmanufacturingfacilityexpectedtobeleased": 106000,
    "descriptionofnatureofrelatedpartyrelationship": "The Company’s most significant shareholder",
    "revenuefromsaleofproductsandsalesbasedroyaltiesfromrelatedpartytransactions": 179000,
    "purchasesofgoodsrelatedpartytransactions": 4078000,
    "servicesreceivedrelatedpartytransactions": 200000,
    "lesseesincrementalborrowingrateappliedtoleaseliabilities": 0.0514,
    "leaseliabilitiesrepaymentterm": "P5Y",
    "amountspayablerelatedpartytransactions": 265000,
    "keymanagementpersonnelcompensationsharebasedpayment": 8037000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2691000,
    "keymanagementpersonnelcompensation": 10728000,
    "financialassetsatamortisedcost": 100041000,
    "financialliabilitiesatamortisedcost": 20160000,
    "percentageofforeigncurrencyforwardexchangecontract": 0.05,
    "percentageofincreasedecreaseinrateofforeigncurrency": 0.05,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 1300000,
    "collaborationinterestbearingadvancedfunding": 281328000,
    "financialliabilities": 36807000,
    "capitalgearingratio": 0.32
  },
  {
    "date": "2022-12-30",
    "symbol": "LEGN",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "o",
    "documentannualreport": "true",
    "documentperiodenddate": "December 31, 2022",
    "currentfiscalyearenddate": "December 31",
    "documenttransitionreport": "o",
    "documentshellcompanyreport": "o",
    "entityfilenumber": "001-39307",
    "entityregistrantname": "LEGEND BIOTECH CORPORATION",
    "entityaddresscountry": "Cayman Islands",
    "entityaddressaddressline1": "Legend Biotech Corporation",
    "entityaddressaddressline2": "2101 Cottontail Lane",
    "entityaddresscityortown": "Somerset",
    "entityaddressstateorprovince": "NJ",
    "entityaddresspostalzipcode": 8873,
    "contactpersonnelname": "Ying Huang",
    "cityareacode": 737,
    "localphonenumber": "317-5050",
    "security12btitle": "American depositary shares, each representing two ordinary shares, par value $0.0001 per share",
    "tradingsymbol": "LEGN",
    "securityexchangename": "Nasdaq Global Select Market",
    "entitycommonstocksharesoutstanding": 330134480,
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entityemerginggrowthcompany": "o",
    "icfrauditorattestationflag": "true",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "o",
    "documentfiscalyearfocus": 2022,
    "entitycentralindexkey": 1801198,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "entityincorporationstatecountrycode": "E9",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Iselin, New Jersey",
    "revenuefromlicensingofintellectualproperty": 650000000,
    "collaborationrevenue": 66677000,
    "otherrevenue": 328000,
    "revenuefromcontractswithcustomers": 117005000,
    "costofsales": 65363000,
    "otherincomeandgains": 12049000,
    "researchanddevelopmentexpense": 335648000,
    "administrativeexpense": 80631000,
    "sellinganddistributionexpenses": 93417000,
    "otherexpensebynature": 9823000,
    "fairvaluelossofwarrantsliabilities": -20900000,
    "financecosts": 10796000,
    "profitlossbeforetax": -445724000,
    "incometaxexpensecontinuingoperations": 625000,
    "profitloss": -446349000,
    "profitlossattributabletoownersofparent": -446349000,
    "basicearningslosspershare": -1.4,
    "dilutedearningslosspershare": -1.4,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 9807000,
    "othercomprehensiveincomethatwillbereclassifiedtoprofitorlossnetoftax": 9807000,
    "othercomprehensiveincome": 9807000,
    "comprehensiveincome": -446349000,
    "comprehensiveincomeattributabletoownersofparent": -436542000,
    "propertyplantandequipment": -25209000,
    "advancepaymentsforpropertyplantandequipment": 914000,
    "rightofuseassets": 11000,
    "intangibleassetsotherthangoodwill": -4096000,
    "collaborationprepaidleases": 65276000,
    "othernoncurrentnonfinancialassets": 1487000,
    "noncurrentassets": 231844000,
    "inventories": 10354000,
    "currenttradereceivables": 90000,
    "currentprepaymentsandothercurrentassets": 61755000,
    "currentfinancialassetsatfairvaluethroughprofitorloss": 185603000,
    "pledgeddeposits": 1270000,
    "timesdeposits": 54016000,
    "cashandcashequivalents": 37399000,
    "currentassets": 1099119000,
    "assets": 1330963000,
    "tradeandotherpayablestotradesuppliers": 32893000,
    "otherpayablesandaccrualscurrent": 10960000,
    "currentgovernmentgrants": 451000,
    "currentleaseliabilities": 3563000,
    "currenttaxliabilities": 9772000,
    "currentderivativefinancialliabilities": 67000000,
    "currentliabilities": 297788000,
    "longtermborrowings": 260932000,
    "noncurrentleaseliabilities": 20039000,
    "noncurrentgovernmentgrants": 7659000,
    "othernoncurrentliabilities": 233000,
    "noncurrentliabilities": 288863000,
    "liabilities": 586651000,
    "issuedcapital": 33000,
    "otherreserves": 744279000,
    "equityattributabletoownersofparent": 744312000,
    "equity": -966456000,
    "equityandliabilities": 1330963000,
    "issueofequity": 377643000,
    "increasedecreasethroughexerciseofoptions": 2929000,
    "increasedecreasethroughreclassificationofvestedrestrictedstockequity": -13850000,
    "increasedecreasethroughsharebasedpaymenttransactions": 34338000,
    "adjustmentsforfinanceincome": 8182000,
    "adjustmentsforfinancecosts": 10796000,
    "adjustmentsfordepreciationexpense": 10173000,
    "gainslossesondisposalsofpropertyplantandequipment": -481000,
    "adjustmentsforamortisationexpense": 2476000,
    "adjustmentsfordepreciationofrightofuseassets": 5743000,
    "adjustmentforfairvaluelossofwarrantliability": -20900000,
    "adjustmentsforfairvaluegainslosses": -593000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 9159000,
    "expensefromsharebasedpaymenttransactionswithemployees": 23600000,
    "deferredgovernmentgrant": -307000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -402540000,
    "adjustmentsfordecreaseincreaseintradeaccountreceivable": 50320000,
    "adjustmentsfordecreaseincreaseinprepaymentsotherreceivableotherassets": -50614000,
    "adjustmentsfordecreaseincreaseinothernoncurrentassets": 3661000,
    "adjustmentsfordecreaseincreaseininventories": -8605000,
    "adjustmentsforgovernmentgrantreceived": 6180000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 25850000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": 165883000,
    "adjustmentsforincreasedecreaseinothernoncurrentliabilities": -163000,
    "increasedecreaseinpledgeddepositsnet": -15000,
    "cashflowsfromusedinoperations": -210043000,
    "financeincomereceivedclassifiedasoperatingactivities": 5580000,
    "incometaxespaidrefundclassifiedasoperatingactivities": -3709000,
    "interestonleasepaymentsclassifiedasoperatingactivities": -527000,
    "cashflowsfromusedinoperatingactivities": -201281000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 20927000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 1348000,
    "prepaymenttocollaboratorforcollaborationrightofuseassets": 14810000,
    "purchaseoffinancialassetsatfairvaluethroughprofitorlossclassifiedasinvestingactivities": 285000000,
    "cashreceivedfromwithdrawaloffinancialassetsatfairvaluethroughprofitorloss": 99990000,
    "cashreceivedfromwithdrawaloffinancialassetsmeasuredatamortizedcost": 30000000,
    "cashreceiptsofinvestmentincomeclassifiedasinvestingactivities": 1252000,
    "additionintimedeposits": 369971000,
    "decreaseintimedeposits": 483617000,
    "decreaseinpledgeddeposits": 105000,
    "cashflowsfromusedininvestingactivities": -77092000,
    "proceedsfromissuanceofordinarysharesforfollowonpublicofferingnetofissuancecosts": 377643000,
    "proceedsfromexerciseofoptions": 2929000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 2596000,
    "cashflowsfromusedinfinancingactivities": 377976000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 99603000,
    "effectofexchangeratechangesoncashandcashequivalents": -2510000,
    "cash": 841317000,
    "shorttermdepositsclassifiedascashequivalents": 1270000,
    "timesdepositscurrentandnoncurrent": 54016000,
    "cashandcashequivalentsasstatedinstatementoffinancialposition": 786031000,
    "cashandcashequivalentsasstatedinstatementofcashflows": 786031000,
    "dateofincorporation": "May 27, 2015",
    "countryofincorporation": "Cayman Islands",
    "addressofregisteredofficeofentity": "PO Box 10240, Harbour Place, 103 South Church Street, George Town, Grant Cayman KY1-1002, Cayman Islands",
    "nameofsubsidiary": "Hainan Chuanji Biotechnology Co., Ltd. (“Hainan Chuanji”)",
    "placeanddateofincorporationofbusinessofsubsidiary": "PRC October 25, 2021",
    "proportionofownershipinterestinsubsidiary": 1,
    "descriptionofnatureofentitysoperationsandprincipalactivities": "General & administrative",
    "upfrontfeesrecognizedasrevenue": 350000000,
    "milestonepaymentreceivable": 210000000,
    "milestonepaymentnoteligibletoreceivebasedonsubsequentchangeindevelopmentplan": 280000000,
    "nonrefundableupfrontamountrecognizedasrevenue": 350000000,
    "milestonepayments": 50000000,
    "estimatedtransactionpricerelatedtocontract": 400000000,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": 10,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": 3,
    "leasetermsandestimatedusefullivesofrightofuseassets": 5,
    "revenue": 300000,
    "noncurrentassetsotherthanfinancialinstrumentsdeferredtaxassetspostemploymentbenefitassetsandrightsarisingunderinsurancecontracts": 231844000,
    "financeincome": 8182000,
    "governmentgrantsreceivedfromlocalgovernmentauthorities": 2434000,
    "otherfinanceincome": 88000,
    "otherincome": 10704000,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": 603000,
    "otherfinancegains": 742000,
    "othergainslosses": 1345000,
    "wagesandsalaries": 147385000,
    "postemploymentbenefitexpensedefinedcontributionplans": 5057000,
    "interestexpenseonleaseliabilities": 527000,
    "interestexpenseonborrowings": 10269000,
    "accountingprofit": 2000000,
    "applicabletaxrate": 0.05,
    "applicabletaxrateonremainingassessableprofits": 0.165,
    "surchargerate": 0.025,
    "withholdingtaxrate": 0.3,
    "nontradingincometaxrate": 0.25,
    "currenttaxrelatingtoitemschargedorcrediteddirectlytoequity": 401000,
    "currentanddeferredtaxrelatingtoitemschargedorcrediteddirectlytoequity": 625000,
    "taxexpenseincomeatstatutoryblendedincometaxrate": -125293000,
    "taxeffectofforeigntaxrates": 15129000,
    "taxeffectsresearchanddevelopmentcredit": -24970000,
    "taxeffectfromchangeintaxrate": -107000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 1829000,
    "taxlossesanddeductibletemporarydifferencesnotrecognized": 131194000,
    "taxeffectofoptionincometaxexpensebenefit": 2668000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": 175000,
    "statutoryblendedincometaxrate": 0.281,
    "taxrateeffectofforeigntaxrates": -0.034,
    "taxrateeffectonresearchanddevelopmentcredit": 0.055999999999999994,
    "taxrateeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": -0.004,
    "taxrateeffectoftaxlosses": -0.294,
    "taxrateeffectofoptionincometaxbenefit": -0.006,
    "averageeffectivetaxrate": -0.001,
    "weightedaverageshares": 318083913,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 17217000,
    "disposalspropertyplantandequipment": 542000,
    "depreciationpropertyplantandequipment": 10173000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -3840000,
    "increasedecreasethroughtransfersfromtoinvestmentpropertypropertyplantandequipment": -40284000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 1264000,
    "disposalsintangibleassetsotherthangoodwill": 6000,
    "amortisationintangibleassetsotherthangoodwill": 2476000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": -57000,
    "valueaddedtaxreceivables": 1396000,
    "prepayments": 16327000,
    "financeleasereceivables": 188000,
    "othernoncurrentassets": 1487000,
    "lesseeleasingarrangementsleasesterm": 50,
    "lesseeleasingarrangementsleasestermdescription": "12 months",
    "additionstorightofuseassets": 23461000,
    "increasedecreasethrougheffectofexchangerealignmentinforeignexchangerate": -411000,
    "depreciationrightofuseassets": 5743000,
    "leaseliabilities": 27159000,
    "increaseinleaseliabilities": 23703000,
    "increaseofleaseliabilitiesbalance": 527000,
    "cashoutflowforleases": 4255000,
    "increasedecreasethrougheffectofchangesinforeignexchangeratesliabilitiesarisingfromfinancingactivities": -9000,
    "expenserelatingtoshorttermleasesforwhichrecognitionexemptionhasbeenused": 1132000,
    "leaseexpenseamountrecognizedinprofitorloss": 7402000,
    "undiscountedfinanceleasepaymentstobereceived": 583000,
    "numberofsharesissued": 9179778,
    "parvaluepershare": 0.0001,
    "rawmaterials": 6989000,
    "workinprogress": 690000,
    "finishedgoods": 2675000,
    "inventoryreserve": 5300000,
    "creditperiodoftradereceivables": 60,
    "amountsreceivablerelatedpartytransactions": 21000,
    "interestreceivable": 1517000,
    "otherreceivables": 41324000,
    "incometaxrefundreceivable": 1003000,
    "prepaymentsotherreceivablesandotherassets": 61755000,
    "financialassetsatamortisedcost": 884436000,
    "cashandbankbalancesatcentralbanks": 21500000,
    "pledgedshorttermdeposits": -1270000,
    "depositsfrombank": -54016000,
    "tradepayablesterm": "30-day",
    "accruedpayroll": 21892000,
    "accruedexpense": 127390000,
    "otherpayables": 10960000,
    "payableforcollaborationassets": 22852000,
    "othertaxpayables": 1015000,
    "tradeandotherpayablestorelatedparties": 2500000,
    "deferredtaxliabilities": 7865000,
    "deferredtaxexpenseincomerecognisedinprofitorlossrelatedtodeferredtaxliabilities": 14896000,
    "deferredtaxassets": 7865000,
    "deferredtaxexpenseincomerecognisedinprofitorlossrelatedtodeferredtaxassets": -14896000,
    "deferredtaxexpenseincome": -149900000,
    "deferredtaxcarryforwardperiod": 5,
    "deferredtaxcarrybackperiod": 1,
    "withholdingtaxpercentage": 0.3,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 190133000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 966542000,
    "deferredtaxassetnotyetrecognized": 1156675000,
    "fairvalueofwarrantliabilityassessed": 67000000,
    "warrantliabilityfairvaluelossgainrecorded": -20900000,
    "warrantliability": 67000000,
    "governmentgrants": 8110000,
    "borrowingsinterestrate": 0.07980000000000001,
    "borrowingsmaturity": "No specific maturity date",
    "noncurrentportionofnoncurrentloansreceived": 260932000,
    "borrowings": 250000000,
    "interestbearingborrowingsfundedinterestsaccrued": 10900000,
    "borrowingsadjustmenttointerestratebasis": 0.024999999999999998,
    "numberofsharesauthorised": 2000000000,
    "authorizedsharecapital": 200000,
    "numberofsharesissuedandfullypaid": 330134480,
    "sharecapitalandsharepremiumnumberofsharesinissue": 330134480,
    "sharecapitalandsharepremium": 1657048000,
    "issuanceofordinarysharesforfollowonpublicofferingnetofissuancecostnumberofsharesinissue": 18722000,
    "issuanceofordinarysharesforinitialpublicofferingnetofissuancecost": 377643000,
    "exerciseofshareoptionnumberofsharesinissue": 2040580,
    "exerciseofshareoption": 4070000,
    "reclassificationofvestedrestrictedstockunitsnumberofsharesinissue": 915048,
    "reclassificationofvestedrestrictedstockunitssharecapitalandsharepremium": 13850000,
    "periodofshareoptionschemeremaininforce": 10,
    "weightedaverageexercisepriceofshareoptionsinsharebasedpaymentarrangementexercisedduringperiodatdateofexercise2019": 22.5813,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 27200000,
    "weightedaveragesharepriceshareoptionsgranted2019": 20.57,
    "expensesrecognizedforshareoptions": 10700000,
    "weightedaveragesharepriceusedinshareoptionfairvalue": 19.4468,
    "numberofoutstandingshareoptions": 9179778,
    "additionalsharecapitalamount": 918,
    "sharepremiumbeforeissueexpenses": 65500000,
    "percentageofoutstandingshareoptions": 0.027999999999999997,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 7.137,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 19.4468,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 4.2888,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 1.8032,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 2.8705,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 2265000,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 573000,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 2041000,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 3281000,
    "exercisepriceofoutstandingshareoptions2019": 11.5,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.623,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.047,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": 7.86,
    "weightedaveragefairvalueatmeasurementdateotherequityinstrumentsgranted": 45300000,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 3386305,
    "percentageofnumberofnumbersharesissued": 0.01,
    "numberofinstrumentsotherequityinstrumentsgranted": 2200000,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 915000,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 500000,
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement2019": 18.3704,
    "weightedaverageexercisepriceofotherequityinstrumentsgrantedinsharebasedpaymentarrangement2019": 20.5695,
    "weightedaverageexercisepriceofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement2019": 15.1354,
    "weightedaverageexercisepriceofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement2019": 17.3746,
    "paidincapitalandreservefunds": 81800000,
    "noncashadditiontointerestbearingadvancedfunding": 130300000.00000001,
    "noncashfairvaluelossgainofwarrantliability": -20900000,
    "noncashadditionstorightofuseassets": 23200000,
    "noncashadditionstoleaseliabilities": 23700000,
    "assetsleasedfromcollaborationpartner": 26500000,
    "noncashadditionstopropertyplantandequipment": 5100000,
    "liabilitiesarisingfromfinancingactivities": 23602000,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 23703000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -2596000,
    "interestpaidclassifiedasoperatingactivities": 527000,
    "cashoutflowforleaseswithinoperatingactivities": 527000,
    "cashoutflowforleaseswithinfinancingactivities": 2596000,
    "cashoutflowforshorttermleases": 1132000,
    "constructionpaymentpayableinfuture": 22706000,
    "areaofmanufacturingfacilityexpectedtobeleased": 106000,
    "descriptionofnatureofrelatedpartyrelationship": "Company controlled by the ultimate holding company",
    "revenuefromsalesbasedroyaltiesfromrelatedpartytransactions": 328000,
    "purchasesofgoodsrelatedpartytransactions": 9189000,
    "servicesreceivedrelatedpartytransactions": 1600000,
    "lesseesincrementalborrowingrateappliedtoleaseliabilities": 0.07940000000000001,
    "leaseliabilitiesrepaymentterm": 5,
    "amountspayablerelatedpartytransactions": 632000,
    "keymanagementpersonnelcompensationsharebasedpayment": 3582000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2170000,
    "keymanagementpersonnelcompensation": 5752000,
    "financialliabilitiesatamortisedcost": 328387000,
    "financialliabilitiesatfairvaluethroughprofitorloss": 67000000,
    "exercisepriceshareoptionsgranted2019": 24.96,
    "percentageofforeigncurrencyforwardexchangecontract": 0.003,
    "percentageofincreasedecreaseinrateofforeigncurrency": -0.05,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 1441000,
    "collaborationinterestbearingadvancedfunding": 260932000,
    "financialliabilities": 398944000,
    "capitalgearingratio": 0.44
  },
  {
    "date": "2021-12-31",
    "symbol": "LEGN",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "LEGEND BIOTECH CORPORATION",
    "entitycentralindexkey": 1801198,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entitycommonstocksharesoutstanding": 308456852,
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "American depositary shares, each representing two ordinary shares, par value $0.0001 per share",
    "tradingsymbol": "LEGN",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-39307",
    "entityincorporationstatecountrycode": "E9",
    "entityaddressaddressline1": "Legend Biotech Corporation",
    "entityaddressaddressline2": "2101 Cottontail Lane",
    "entityaddresscityortown": "Somerset",
    "entityaddresscountry": "KY",
    "entityaddresspostalzipcode": "NJ 08873",
    "contactpersonnelname": "Ying Huang",
    "entityaddressstateorprovince": "NJ",
    "cityareacode": 737,
    "localphonenumber": "317-5050",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "documentregistrationstatement": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorfirmid": 1408,
    "auditorname": "Ernst & Young Hua Ming LLP",
    "auditorlocation": "Shanghai, the People’s Republic of China",
    "revenuefromcontractswithcustomers": 89792000,
    "otherincome": 2742000,
    "researchanddevelopmentexpense": 313346000,
    "administrativeexpense": 46939000,
    "sellinganddistributionexpenses": 102542000,
    "otherexpensebynature": 9132000,
    "fairvaluelossofwarrantsliabilities": 6200000,
    "financecosts": 900000,
    "profitlossbeforetax": -386208000,
    "incometaxexpensecontinuingoperations": 1000,
    "profitloss": -386209000,
    "profitlossattributabletoownersofparent": -386209000,
    "basicearningslosspershare": -1.37,
    "dilutedearningslosspershare": -1.37,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 10620000,
    "othercomprehensiveincomethatwillbereclassifiedtoprofitorlossnetoftax": 10620000,
    "othercomprehensiveincome": 10620000,
    "comprehensiveincome": -375589000,
    "comprehensiveincomeattributabletoownersofparent": -375589000,
    "propertyplantandequipment": 145724000,
    "advancepaymentsforpropertyplantandequipment": 2168000,
    "rightofuseassets": 7186000,
    "timesdepositsnoncurrent": 4705000,
    "intangibleassetsotherthangoodwill": 4684000,
    "othernoncurrentnonfinancialassets": 5148000,
    "noncurrentassets": 169615000,
    "inventories": 1749000,
    "currenttradereceivables": 50410000,
    "currentprepaymentsandothercurrentassets": 12754000,
    "financialassetsmeasuredatamortizedcost": 29937000,
    "pledgeddeposits": -1444000,
    "timesdeposits": 163520000,
    "cashandcashequivalents": 688938000,
    "currentassets": 948752000,
    "assets": 1118367000,
    "tradeandnotespayables": 7043000,
    "otherpayablesandaccrualscurrent": 123464000,
    "currentgovernmentgrants": 304000,
    "currentleaseliabilities": 911000,
    "currentderivativefinancialliabilities": 87900000,
    "currentcontractliabilities": 60644000,
    "currentliabilities": 280266000,
    "longtermborrowings": 120462000,
    "noncurrentcontractliabilities": 242578000,
    "noncurrentleaseliabilities": 1593000,
    "noncurrentgovernmentgrants": 1866000,
    "othernoncurrentliabilities": 396000,
    "noncurrentliabilities": 366895000,
    "liabilities": 647161000,
    "issuedcapital": 31000,
    "otherreserves": 471175000,
    "equityattributabletoownersofparent": 471206000,
    "equity": 471206000,
    "equityandliabilities": 1118367000,
    "issueofequity": 2000,
    "issuanceofordinarysharerelatingtoprivateplacementforinstitutionalinvestor": 2000,
    "increasedecreasethroughexerciseofoptions": 6089000,
    "increasedecreasethroughreclassificationofvestedrestrictedstockequity": 5323000,
    "increasedecreasethroughsharebasedpaymenttransactions": 20158000,
    "retainedearnings": 471200000,
    "adjustmentsforfinanceincome": 971000,
    "adjustmentsforfinancecosts": 900000,
    "adjustmentsforimpairmentlossreversalofimpairmentlossrecognisedinprofitorlosstradeandotherreceivables": -22000,
    "adjustmentsfordepreciationexpense": 11046000,
    "gainslossesondisposalsofpropertyplantandequipment": -974000,
    "adjustmentsforamortisationexpense": 1379000,
    "adjustmentsfordepreciationofrightofuseassets": 1492000,
    "adjustmentforfairvaluelossofwarrantliability": 6200000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 4867000,
    "expensefromsharebasedpaymenttransactionswithemployees": 20158000,
    "deferredgovernmentgrant": -295000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -340480000,
    "adjustmentsfordecreaseincreaseintradeaccountreceivable": 24590000,
    "adjustmentsfordecreaseincreaseinprepaymentsotherreceivableotherassets": -2966000,
    "adjustmentsfordecreaseincreaseinothercurrentassets": -1175000,
    "adjustmentsfordecreaseincreaseininventories": 51000,
    "adjustmentsforgovernmentgrantreceived": 80000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 1805000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": 142091000,
    "adjustmentsforincreasedecreaseinothernoncurrentliabilities": -158000,
    "increasedecreaseincontractliabilities": -22310000,
    "increasedecreaseinpledgeddepositsnet": -1060000,
    "cashflowsfromusedinoperations": -199532000,
    "financeincomereceivedclassifiedasoperatingactivities": 652000,
    "incometaxespaidrefundclassifiedasoperatingactivities": -557000,
    "interestonleasepaymentsclassifiedasoperatingactivities": -142000,
    "cashflowsfromusedinoperatingactivities": -198465000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 43905000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 3207000,
    "purchaseoffinancialassetsatfairvaluethroughprofitorlossclassifiedasinvestingactivities": 50000000,
    "cashreceivedfromwithdrawaloffinancialassetsatfairvaluethroughprofitorloss": 50081000,
    "proceedsfromdisposalsofpropertyplantandequipmentintangibleassetsotherthangoodwillinvestmentpropertyandothernoncurrentassets": 4000,
    "additionintimedeposits": 298107000,
    "decreaseintimedeposits": 180000000,
    "purchaseoffinancialassetsmeasuredatamortizedcost": 29849000,
    "cashflowsfromusedininvestingactivities": -194983000,
    "proceedsfromissuanceofordinarysharesforfollowonpublicofferingnetofissuancecosts": 323440000,
    "proceedsfromissuanceofordinarysharesandwarrantrelatingtoprivateplacementforaninstitutionalinvestor": 300000000,
    "proceedsfromexerciseofoptions": 4642000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 1419000,
    "cashflowsfromusedinfinancingactivities": 626663000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 233215000,
    "effectofexchangeratechangesoncashandcashequivalents": 34000,
    "cash": 858607000,
    "shorttermdepositsclassifiedascashequivalents": 1444000,
    "timesdepositscurrentandnoncurrent": 168225000,
    "cashandcashequivalentsasstatedinstatementoffinancialposition": 688938000,
    "cashandcashequivalentsasstatedinstatementofcashflows": 688938000,
    "addressofregisteredofficeofentity": "PO Box 10240, Harbour Place, 103 South Church Street, George Town, Grant Cayman KY1-1002, Cayman Islands",
    "countryofincorporation": "Cayman Islands",
    "dateofincorporation": "2015-05-27",
    "nameofsubsidiary": "Legend Biotech Limited (“Legend   BVI”)",
    "placeanddateofincorporationofbusinessofsubsidiary": "The British VirginIslandsJune 2, 2015",
    "proportionofownershipinterestinsubsidiary": 1,
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Investment holding",
    "descriptionofrecognizeshorttermleasesandleasesoflowvalueassets": "The Group applies the short-term lease recognition exemption to its short-term leases that is those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase option. Lease payments on short-term leases are recognized as an expense on a straight-line basis over the lease term.",
    "cashandcashequivalentsmaturity": "P3M",
    "nonrefundableupfrontamountrecognizedasrevenue": 350000000,
    "milestonepayments": 125000000,
    "estimatedtransactionpricerelatedtocontract": 400000000,
    "upfrontfeesrecognizedasrevenue": 350000000,
    "numberofmilestonepayments": 1,
    "milestoneachievementclinicalmilestone": 75000000,
    "numberofadditionalmilestonepayments": 3,
    "additionalmilestonepaymentreceivable": 65000000,
    "milestonepaymentreceivable": 1100000000,
    "milestonepaymentnoteligibletoreceivebasedonsubsequentchangeindevelopmentplan": 280000000,
    "descriptionofusefullifepropertyplantandequipment": "Not depreciated",
    "depreciationratepropertyplantandequipment": 0.02,
    "amortisationmethodintangibleassetsotherthangoodwill": "3-10 years",
    "leasetermsandestimatedusefullivesofrightofuseassets": "P2Y",
    "deferredtaxassetnotyetrecognized": 224200000,
    "expensefromequitysettledsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 2400000,
    "revenue": 86368000,
    "noncurrentassetsotherthanfinancialinstrumentsdeferredtaxassetspostemploymentbenefitassetsandrightsarisingunderinsurancecontracts": 103648000,
    "informationaboutmajorcustomers": "single customer",
    "revenuefromlicensingandroyalties": 3424000,
    "revenuefromlicensingofintellectualproperty": 4905000,
    "revenuefromjointsteeringcommitteeservice": 81463000,
    "estimatedserviceperiod": "P9Y",
    "righttouselicenseamount": 554900000,
    "performanceobligationsestimatedcollaborationperiod": "P9Y",
    "revenuethatwasincludedincontractliabilitybalanceatbeginningofperiod": 54523000,
    "revenuefromperformanceobligationssatisfiedorpartiallysatisfiedinpreviousperiods": 4905000,
    "transactionpriceallocatedtoremainingperformanceobligations": 60644000,
    "financeincome": 971000,
    "governmentgrantsreceivedfromlocalgovernmentauthorities": 1736000,
    "otherfinanceincome": 35000,
    "otherfinancegains": 317000,
    "othergainslosses": 317000,
    "otherincomeandgains": 3059000,
    "lossesondisposalsofpropertyplantandequipment": 974000,
    "followonexpenses": 400000,
    "wagesandsalaries": 105751000,
    "postemploymentbenefitexpensedefinedcontributionplans": 2257000,
    "interestexpenseonleaseliabilities": 142000,
    "interestexpenseonborrowings": 758000,
    "accountingprofit": 2000000,
    "applicabletaxrate": 0.0825,
    "applicabletaxrateonremainingassessableprofits": 0.165,
    "surchargerate": 0.025,
    "withholdingtaxrate": 0.3,
    "nontradingincometaxrate": 0.25,
    "currenttaxrelatingtoitemschargedorcrediteddirectlytoequity": 1000,
    "currentanddeferredtaxrelatingtoitemschargedorcrediteddirectlytoequity": 1000,
    "taxexpenseincomeatstatutoryblendedincometaxrate": -108563000,
    "taxeffectofforeigntaxrates": 16347000,
    "taxeffectsresearchanddevelopmentcredit": -20637000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 1036000,
    "taxlossesanddeductibletemporarydifferencesnotrecognized": 121623000,
    "taxeffectofoptionincometaxexpensebenefit": -9532000,
    "adjustmentsforcurrenttaxofpriorperiod": 1000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": -274000,
    "statutoryblendedincometaxrate": 0.281,
    "taxrateeffectofforeigntaxrates": -0.042,
    "taxrateeffectonresearchanddevelopmentcredit": 0.053,
    "taxrateeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": -0.003,
    "taxrateeffectoftaxlosses": -0.315,
    "taxrateeffectofoptionincometaxbenefit": 0.025,
    "othertaxrateeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": 0.001,
    "weightedaverageshares": 281703291,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 1603000,
    "disposalspropertyplantandequipment": 859000,
    "depreciationpropertyplantandequipment": 3787000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": 123000,
    "increasedecreasethroughtransfersfromtoinvestmentpropertypropertyplantandequipment": 14749000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 3207000,
    "amortisationintangibleassetsotherthangoodwill": 1379000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": 4000,
    "valueaddedtaxreceivables": 4080000,
    "prepayments": 1068000,
    "othernoncurrentassets": 5148000,
    "lesseeleasingarrangementsleasesterm": "P2Y",
    "lesseeleasingarrangementsleasestermdescription": "12 months or less",
    "numberofcarparkingspaces": 5,
    "lessorleasingarrangementleaseterm": "P12M",
    "rentalincome": 13000,
    "increaserightofuseassets": 678000,
    "rightofuseassetsdisposal": -59000,
    "increasedecreasethrougheffectofexchangerealignmentinforeignexchangerate": 112000,
    "depreciationrightofuseassets": 101000,
    "leaseliabilities": 2504000,
    "increaseinleaseliabilities": 678000,
    "leaseliabilitiesdisposal": -68000,
    "increaseofleaseliabilitiesbalance": 142000,
    "cashoutflowforleases": 1561000,
    "increasedecreasethrougheffectofchangesinforeignexchangeratesliabilitiesarisingfromfinancingactivities": -60000,
    "expenserelatingtoshorttermleasesforwhichrecognitionexemptionhasbeenused": 182000,
    "leaseexpenseamountrecognizedinprofitorloss": 1816000,
    "undiscountedoperatingleasepaymentstobereceived": 13000,
    "numberofsharesissued": 20591629,
    "parvaluepershare": 7.792,
    "percentageofdividends": 0.08,
    "descriptionofautomaticconversion": "Each Series A Preference Share will be automatically converted upon the closing of a Qualified IPO into a number of ordinary shares as is determined by dividing the Series A original issue price by a conversion price is equal to the lower of (i) the conversion price at the time in effect for such Series A Preference Share and (ii) the price per share that equals 90% of the lowest net price per ordinary share received by the Company in the Qualified IPO.",
    "descriptionofredemptionrights": "At any time on or after the occurrence of a Trigger Event (as defined below), each investor may require the Company to redeem the Series A Preference Shares issued to the investor and require the Company to immediately pay the investor an amount equal to the redemption price, plus 8% annualized.",
    "fairvaluelosses": 80000000,
    "currentrawmaterialsandcurrentproductionsupplies": 1749000,
    "creditperiodoftradereceivables": "P30D",
    "percentageofconcentrationofcreditriskoftradereceivablesduefromonesinglecustomerunderlicenseandcollaborationagreement": 0.992,
    "amountsreceivablerelatedpartytransactions": 50000000,
    "reversalofimpairmentlossrecognisedinprofitorlosstradereceivables": 22000,
    "interestreceivable": 230000,
    "otherreceivables": 836000,
    "incometaxrefundreceivable": 3709000,
    "prepaymentsotherreceivablesandotherassets": 12754000,
    "financialassetsatamortisedcost": 29937000,
    "financialassetsdiscountedbidyieldpercentage": 0.005,
    "financialassetsmeasuredatamortizedcostmaturitydate": "2022-06-01",
    "cashandbankbalancesatcentralbanks": 858607000,
    "pledgedshorttermdeposits": -1444000,
    "depositsfrombank": -168225000,
    "tradeandotherpayablestotradesuppliers": 7043000,
    "tradepayablesterm": "P30D",
    "accruedpayroll": 19207000,
    "accruedexpense": 86875000,
    "otherpayables": 16867000,
    "othertaxpayables": 515000,
    "tradeandotherpayablestorelatedparties": 3300000,
    "contractliabilities": 303222000,
    "contractliabilitypaymentsreceivedduetoreceive": 64058000,
    "contractliabilitytransferredtorevenue": 86368000,
    "contractliabilityexchangerealignment": -4553000,
    "deferredtaxexpenseincome": -38000,
    "deferredtaxcarryforwardperiod": "P5Y",
    "deferredtaxcarrybackperiod": "P1Y",
    "withholdingtaxpercentage": 0.1,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 102435000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 381686000,
    "warrantliabilityassessed": 81700000,
    "fairvalueofwarrantliabilityassessed": 87900000,
    "warrantliabilityfairvaluelossrecorded": 6200000,
    "warrantliability": 87900000,
    "governmentgrants": 2170000,
    "borrowingsinterestrate": 0.0303,
    "borrowingsmaturity": "No specific maturity date",
    "noncurrentportionofnoncurrentloansreceived": 120462000,
    "borrowings": 119700000,
    "borrowingsadjustmenttointerestratebasis": 0.025,
    "borrowingsinterestratebasis": "The respective interest rate of each borrowing is based on the average annual London Interbank Offered Rate (LIBOR) for U.S. Dollars as reported in the Wall Street Journal on the due date of the quarterly invoice or the next business date should the due date fall on a weekend or holiday, plus 250 basis points, calculated on the number of days from the date on which the Company applied such borrowings.",
    "interestbearingborrowingsfundedinterestsaccrued": 800000,
    "authorizedsharecapital": 200000,
    "numberofsharesauthorised": 2000000000,
    "numberofsharesissuedandfullypaid": 308456852,
    "sharecapitalandsharepremiumnumberofsharesinissue": 308456852,
    "issuanceofordinarysharesrelatingtoprivateplacementforinstitutionalinvestornumberofsharesissue": 20809850,
    "issuanceofordinarysharesforfollowonpublicofferingnetofissuancecostnumberofsharesinissue": 17231150,
    "exerciseofshareoptionnumberofsharesinissue": 4056380,
    "reclassificationofvestedrestrictedstockunitsnumberofsharesinissue": 349216,
    "sharecapitalandsharepremium": 31000,
    "issuanceofordinarysharesforinitialpublicofferingnetofissuancecost": 2000,
    "exerciseofshareoption": 6089000,
    "reclassificationofvestedrestrictedstockunitssharecapitalandsharepremium": 5323000,
    "dateofgrantofsharebasedpaymentarrangement": "December 21, 2017",
    "periodofshareoptionschemeremaininforce": "P10Y",
    "weightedaverageexercisepriceofshareoptionsinsharebasedpaymentarrangementexercisedduringperiodatdateofexercise2019": 18.4846,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 5700000,
    "weightedaveragesharepriceshareoptionsgranted2019": 9.497,
    "expensesrecognizedforshareoptions": 2400000,
    "weightedaveragesharepriceusedinshareoptionfairvalue": 15.4774,
    "numberofoutstandingshareoptions": 9529,
    "additionalsharecapitalamount": 953,
    "sharepremiumbeforeissueexpenses": 27600000,
    "percentageofoutstandingshareoptions": 0.031,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 2.897,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 15.4774,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 2.9987,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 1.3346,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 1.4334,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 595,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 1251,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 4056,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 2828,
    "exercisepriceofoutstandingshareoptions2019": 0.5,
    "shareoptionsexerciseperiod": "2019-12-25",
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.732,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0003,
    "descriptionofoptionlifeshareoptionsgranted": 10,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P8Y1M28D",
    "weightedaveragefairvalueatmeasurementdateotherequityinstrumentsgranted": 32000000,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 2601000,
    "percentageofnumberofnumbersharesissued": 0.008,
    "numberofinstrumentsotherequityinstrumentsgranted": 2133000,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 349000,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 296000,
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement2019": 15.1808,
    "weightedaverageexercisepriceofotherequityinstrumentsgrantedinsharebasedpaymentarrangement2019": 15.012,
    "weightedaverageexercisepriceofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement2019": 15.242,
    "weightedaverageexercisepriceofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement2019": 14.4913,
    "paidincapitalandreservefunds": 70400000,
    "noncashadditiontointerestbearingloansandborrowings": 119700000,
    "noncashfairvaluelossofwarrantliability": 6200000,
    "noncashprepaymentinexchangeofresearchanddevelopmentservice": 1500000,
    "noncashadditionstorightofuseassets": 700000,
    "noncashadditionstoleaseliabilities": 700000,
    "noncashadditionstopropertyplantandequipment": 14200000,
    "liabilitiesarisingfromfinancingactivities": 2504000,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": 678000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -1419000,
    "increasedecreasethroughdisposalliabilitiesarisingfromfinancingactivities": -68000,
    "interestpaidclassifiedasoperatingactivities": 142000,
    "cashoutflowforleaseswithinoperatingactivities": 142000,
    "cashoutflowforleaseswithinfinancingactivities": 1419000,
    "cashoutflowforshorttermleases": 182000,
    "constructionpaymentpayableinfuture": 25897000,
    "descriptionofnatureofrelatedpartyrelationship": "Company controlled by the ultimate holding company",
    "revenuefromlicensingofpatentsrelatedpartytransactions": 3019000,
    "revenuefromsalesbasedroyaltiesfromrelatedpartytransactions": 405000,
    "otherincomerelatedpartytransactions": 12000,
    "purchasesofgoodsrelatedpartytransactions": 9615000,
    "compensationfeeforterminationofserviceagreement": 2666000,
    "financingfromfollowonpublicofferingnetofissuancecost": 84600000,
    "servicesreceivedrelatedpartytransactions": 1600000,
    "lesseesincrementalborrowingrateappliedtoleaseliabilities": 0.02,
    "leaseliabilitiesrepaymentterm": "P5Y",
    "amountspayablerelatedpartytransactions": 2301000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 1942000,
    "keymanagementpersonnelcompensationsharebasedpayment": 2907000,
    "keymanagementpersonnelcompensation": 4849000,
    "financialliabilitiesatamortisedcost": 7043000,
    "financialliabilitiesatfairvaluethroughprofitorloss": 87900000,
    "percentageofforeigncurrencyforwardexchangecontract": 0.35,
    "percentageofincreasedecreaseinrateofforeigncurrency": 0.05,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 1215000,
    "tradeandotherpayables": 7043000,
    "interestbearingloanandborrowings": 120462000,
    "financialliabilities": 112721000,
    "capitalgearingratio": 0.58
  },
  {
    "date": "2020-12-31",
    "symbol": "LEGN",
    "period": "FY",
    "documenttype": "20-F",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "LEGEND BIOTECH CORPORATION",
    "entitycentralindexkey": 1801198,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entitycommonstocksharesoutstanding": 266010256,
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Ordinary shares, par value $0.0001 per share",
    "tradingsymbol": "LEGN",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-39307",
    "entityincorporationstatecountrycode": "E9",
    "entityaddressaddressline1": "Legend Biotech Corporation",
    "entityaddressaddressline2": "2101 Cottontail Lane",
    "entityaddresscityortown": "Somerset",
    "entityaddresscountry": "KY",
    "entityaddresspostalzipcode": "NJ 08873",
    "contactpersonnelname": "Ying Huang",
    "cityareacode": 737,
    "localphonenumber": "317-5050",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "documentregistrationstatement": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "revenuefromcontractswithcustomers": 75676000,
    "otherincome": 6119000,
    "researchanddevelopmentexpense": 232160000,
    "administrativeexpense": 23147000,
    "sellinganddistributionexpenses": 49571000,
    "otherexpensebynature": 346000,
    "fairvaluelossofconvertibleredeemablepreferredshares": 79984000,
    "financecosts": 4209000,
    "profitlossbeforetax": -307622000,
    "incometaxexpensecontinuingoperations": -4145000,
    "profitloss": -303477000,
    "profitlossattributabletoownersofparent": -303477000,
    "basicearningslosspershare": -1.28,
    "dilutedearningslosspershare": -1.28,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -2142000,
    "othercomprehensiveincomethatwillbereclassifiedtoprofitorlossnetoftax": -2142000,
    "othercomprehensiveincome": -2142000,
    "comprehensiveincome": -303477000,
    "comprehensiveincomeattributabletoownersofparent": -305619000,
    "propertyplantandequipment": -13408000,
    "advancepaymentsforpropertyplantandequipment": 224000,
    "rightofuseassets": 3158000,
    "othernoncurrentnonfinancialassets": 3973000,
    "intangibleassetsotherthangoodwill": -334000,
    "noncurrentassets": 128149000,
    "inventories": 1800000,
    "currenttradereceivables": 75000000,
    "currentprepaymentsandothercurrentassets": 10007000,
    "shorttermdepositsclassifiedascashequivalents": 384000,
    "timedeposit": 50000000,
    "cashandcashequivalents": 189000,
    "currentassets": 592858000,
    "assets": 721007000,
    "tradeandnotespayables": 5238000,
    "otherpayablesandaccrualscurrent": 85559000,
    "currentgovernmentgrants": 283000,
    "currentleaseliabilities": 1464000,
    "currentcontractliabilities": 55014000,
    "currentliabilities": 161167000,
    "noncurrentcontractliabilities": 275071000,
    "noncurrentleaseliabilities": 1909000,
    "othernoncurrentliabilities": 554000,
    "noncurrentgovernmentgrants": 2051000,
    "noncurrentliabilities": 279585000,
    "liabilities": 440752000,
    "issuedcapital": 27000,
    "retainedearnings": 280228000,
    "equityattributabletoownersofparent": 280255000,
    "equity": -430759000,
    "equityandliabilities": 721007000,
    "increasedecreasethroughconversionofconvertibleinstruments": 240434000,
    "issueofequity": 160450000,
    "increasedecreasethroughexerciseofoptions": 1464000,
    "increasedecreasethroughsharebasedpaymenttransactions": 4760000,
    "adjustmentsforfinanceincome": 2930000,
    "adjustmentsforfinancecosts": 4209000,
    "adjustmentsforimpairmentlossreversalofimpairmentlossrecognisedinprofitorlosstradeandotherreceivables": 13000,
    "adjustmentsfordepreciationexpense": 8248000,
    "gainslossesondisposalsofpropertyplantandequipment": -55000,
    "adjustmentsforamortisationexpense": 192000,
    "adjustmentsfordepreciationofrightofuseassets": 1493000,
    "adjustmentsforfairvaluegainlossofconvertibleredeemablepreferredshares": 79984000,
    "adjustmentsforfairvaluegainslosses": -47000,
    "adjustmentsforunrealisedforeignexchangelossesgains": -66000,
    "expensefromsharebasedpaymenttransactionswithemployees": 2855000,
    "deferredgovernmentgrant": -114000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -211825000,
    "adjustmentsfordecreaseincreaseintradeaccountreceivable": -45000000,
    "adjustmentsfordecreaseincreaseinprepaymentsotherreceivableotherassets": 3366000,
    "adjustmentsfordecreaseincreaseinothercurrentassets": -3973000,
    "adjustmentsfordecreaseincreaseininventories": -643000,
    "adjustmentsforgovernmentgrantreceived": 2452000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -4348000,
    "adjustmentsforincreasedecreaseinotheroperatingpayables": 20230000,
    "adjustmentsforincreasedecreaseinothernoncurrentliabilities": 554000,
    "increasedecreaseincontractliabilities": 6026000,
    "increaseofpledgedshorttermdepositsnet": -128000,
    "cashflowsfromusedinoperations": -233289000,
    "incometaxespaidclassifiedasoperatingactivities": 278000,
    "financeincomereceivedclassifiedasoperatingactivities": 3366000,
    "incometaxespaidrefundclassifiedasoperatingactivities": -7391000,
    "interestonleasepaymentsclassifiedasoperatingactivities": -195000,
    "cashflowsfromusedinoperatingactivities": -223005000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 45747000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 4029000,
    "purchaseoffinancialassetsatfairvaluethroughprofitorlossclassifiedasinvestingactivities": 22682000,
    "cashreceivedfromwithdrawaloffinancialassetsatfairvaluethroughprofitorloss": 22682000,
    "cashreceiptsofinvestmentincomeclassifiedasinvestingactivities": 47000,
    "proceedsfromdisposalsofpropertyplantandequipmentintangibleassetsotherthangoodwillinvestmentpropertyandothernoncurrentassets": 1000,
    "additionofshorttermtimedepositsclassifiedasinvestingactivities": 50000000,
    "decreaseinshorttermdepositsclassifiedasinvestingactivities": 75559000,
    "cashflowsfromusedininvestingactivities": -24169000,
    "cashrepaymentsofadvancesandloansfromrelatedparties": 4000,
    "proceedsfromissueofpreferenceshares": 160450000,
    "proceedsfromissueofordinaryshares": 450085000,
    "proceedsfromissuanceofordinarysharesrelatingtoprivateplacement": 12000000,
    "proceedsfromexerciseofoptions": 1464000,
    "paymentsofexpensesforissuanceofconvertibleredeemablepreferredshares": 2514000,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 2602000,
    "cashflowsfromusedinfinancingactivities": 618879000,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 371705000,
    "effectofexchangeratechangesoncashandcashequivalents": 620000,
    "cash": 506073000,
    "cashandcashequivalentsasstatedinstatementoffinancialposition": 455689000,
    "cashandcashequivalentsasstatedinstatementofcashflows": 455689000,
    "addressofregisteredofficeofentity": "PO Box 10240, Harbour Place, 103 South Church Street, George Town, Grant Cayman KY1-1002, Cayman Islands",
    "countryofincorporation": "Cayman Islands",
    "dateofincorporation": "2015-05-27",
    "nameofsubsidiary": "Legend Biotech (Netherlands) B.V.   (“Legend Netherlands”)",
    "placeanddateofincorporationofbusinessofsubsidiary": "NetherlandsJune 12, 2017",
    "proportionofownershipinterestinsubsidiary": 1,
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Sale of life scienceresearch products",
    "descriptionofrecognizeshorttermleasesandleasesoflowvalueassets": "The Group applies the short-term lease recognition exemption to its short-term leases that is those leases that have a lease term of 12 months or less from the commencement date and do not contain a purchase option.Lease payments on short-term leases are recognised as an expense on a straight-line basis over the lease term.",
    "cashandcashequivalentsmaturity": "P3M",
    "nonrefundableupfrontamountrecognizedasrevenue": 350000000,
    "milestonepayments": 50000000,
    "estimatedtransactionpricerelatedtocontract": 400000000,
    "upfrontfeesrecognizedasrevenue": 350000000,
    "numberofmilestonepayments": 1,
    "milestoneachievementclinicalmilestone": 75000000,
    "milestonepaymentreceivable": 125000000,
    "additionalmilestonepaymentreceivable": 210000000,
    "descriptionofusefullifepropertyplantandequipment": "Not depreciated",
    "depreciationratepropertyplantandequipment": 0.1,
    "amortisationmethodintangibleassetsotherthangoodwill": "3-10 years",
    "leasetermsandestimatedusefullivesofrightofuseassets": "P10Y",
    "deferredtaxassetnotyetrecognised": 218508000,
    "expensefromequitysettledsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 1905000,
    "revenue": 75676000,
    "noncurrentassetsotherthanfinancialinstrumentsdeferredtaxassetspostemploymentbenefitassetsandrightsarisingunderinsurancecontracts": 128149000,
    "informationaboutmajorcustomers": "single customer",
    "revenuefromlicensingofintellectualproperty": 40200000,
    "revenuefromjointsteeringcommitteeservice": 70051000,
    "righttouselicenseamount": 494800000,
    "estimatedserviceperiod": "P9Y",
    "performanceobligationsestimatedcollaborationperiod": "P9Y",
    "revenuethatwasincludedincontractliabilitybalanceatbeginningofperiod": 46777000,
    "revenuefromperformanceobligationssatisfiedorpartiallysatisfiedinpreviousperiods": 21216000,
    "transactionpriceallocatedtoremainingperformanceobligations": 330085000,
    "netforeignexchangegain": 66000,
    "governmentgrantsreceivedfromlocalgovernmentauthorities": 3072000,
    "financeincome": 2930000,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": 47000,
    "rentalincome": 4000,
    "lossesondisposalsofpropertyplantandequipment": 55000,
    "initialpublicofferingexpenses": 1439000,
    "wagesandsalaries": 70682000,
    "postemploymentbenefitexpensedefinedcontributionplans": 640000,
    "interestexpenseonleaseliabilities": 195000,
    "expensesforissuanceofconvertibleredeemablepreferredshares": 4014000,
    "applicabletaxrate": 0.05,
    "withholdingtaxrate": 0.15,
    "statutoryblendedincometaxrate": 0.301,
    "accountingprofit": 200000,
    "currenttaxrelatingtoitemschargedorcrediteddirectlytoequity": -532000,
    "currentanddeferredtaxrelatingtoitemschargedorcrediteddirectlytoequity": -4145000,
    "taxexpenseincomeatstatutoryblendedincometaxrate": -92548000,
    "taxeffectofforeigntaxrates": 38012000,
    "taxeffectsresearchanddevelopmentcredit": -6451000,
    "taxeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": 1817000,
    "taxlossesanddeductibletemporarydifferencesnotrecognized": 55898000,
    "taxeffectofoptionincometaxexpensebenefit": -1331000,
    "adjustmentsforcurrenttaxofpriorperiod": 658000,
    "uncertaintaxpositions": -272000,
    "withholdingtaxoninterest": 278000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": -206000,
    "taxrateeffectofforeigntaxrates": -0.124,
    "taxrateeffectonresearchanddevelopmentcredit": 0.021,
    "taxrateeffectofexpensenotdeductibleindeterminingtaxableprofittaxloss": -0.006,
    "taxrateeffectoftaxlosses": -0.182,
    "taxrateeffectofoptionincometaxbenefit": 0.004,
    "taxrateeffectofadjustmentsforcurrenttaxofpriorperiods": -0.002,
    "taxrateeffectonuncertaintaxpositions": 0.001,
    "taxrateeffectonwithholdingtaxoninterest": -0.001,
    "othertaxrateeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": 0.001,
    "averageeffectivetaxrate": 0.013,
    "weightedaverageshares": 236305234,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 13663000,
    "disposalspropertyplantandequipment": 165000,
    "depreciationpropertyplantandequipment": 8248000,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": 1368000,
    "increasedecreasethroughtransfersfromconstructioninprogresspropertyplantandequipment": -22810000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 2583000,
    "amortisationintangibleassetsotherthangoodwill": 192000,
    "increasedecreasethroughnetexchangedifferencesintangibleassetsotherthangoodwill": -58000,
    "valueaddedtaxreceivables": 1941000,
    "prepayments": 3455000,
    "othernoncurrentassets": 3973000,
    "lesseeleasingarrangementsleasesterm": "P50Y",
    "lesseeleasingarrangementsleasestermdescription": "12 months or less",
    "numberofcarparkingspaces": 5,
    "lessorleasingarrangementleaseterm": "P12M",
    "increaserightofuseassets": 491000,
    "leasemodification": -928000,
    "increasedecreasethroughnetexchangedifferencesrightofuseassets": 591000,
    "depreciationrightofuseassets": 1493000,
    "leaseliabilities": 3563000,
    "increaseinleaseliabilities": 491000,
    "leaseliabilitiesleasemodifications": -928000,
    "increaseofleaseliabilitiesbalance": 195000,
    "cashoutflowforleases": 2866000,
    "increasedecreasethrougheffectofchangesinforeignexchangeratesliabilitiesarisingfromfinancingactivities": 327000,
    "expenserelatingtoshorttermleasesforwhichrecognitionexemptionhasbeenused": 69000,
    "leaseexpenseamountrecognizedinprofitorloss": 1757000,
    "undiscountedoperatingleasepaymentstobereceived": 4000,
    "numberofsharesissued": 14241000,
    "parvaluepershare": 0.0001,
    "percentageofdividends": 0.08,
    "descriptionofautomaticconversion": "Each Series A Preference Share will be automatically converted upon the closing of a Qualified IPO into a number of ordinary shares as is determined by dividing the Series A original issue price by a conversion price is equal to the lower of (i) the conversion price at the time in effect for such Series A Preference Share and (ii) the price per share that equals 90% of the lowest net price per ordinary share received by the Company in the Qualified IPO.",
    "descriptionofredemptionrights": "At any time on or after the occurrence of a Trigger Event (as defined below), each investor may require the Company to redeem the Series A Preference Shares issued to the investor and require the Company to immediately pay the investor an amount equal to the redemption price, plus 8% annualized.",
    "fairvalueloss": 79984000,
    "conversiontoordinaryshares": -240434000,
    "currentrawmaterialsandcurrentproductionsupplies": 1800000,
    "allowanceaccountforcreditlossesoffinancialassets": 22000,
    "creditperiodoftradereceivables": "P90D",
    "percentageofconcentrationofcreditriskoftradereceivablesduefromonesinglecustomerunderlicenseandcollaborationagreement": 1,
    "reversalofimpairmentlossrecognisedinprofitorlosstradereceivables": 9000,
    "impairmentlossrecognisedinprofitorlosstradereceivables": 22000,
    "expectedcreditlossrate": 0.0003,
    "interestreceivable": 80000,
    "otherreceivables": 264000,
    "incometaxrefundreceivable": 4267000,
    "prepaymentsotherreceivablesandotherassets": 10007000,
    "amountsreceivablerelatedpartytransactions": 14000,
    "cashandbankbalancesatcentralbanks": 4335000,
    "pledgedshorttermdeposits": -384000,
    "depositsfrombank": -50000000,
    "tradeandotherpayablestotradesuppliers": 2103000,
    "notespayables": 327000,
    "tradepayablesterm": "P60D",
    "accruedpayroll": 13609000,
    "otherpayables": 85559000,
    "tradeandotherpayablestorelatedparties": 3736000,
    "contractliabilities": 330085000,
    "contractliabilityadvancereceiveddueforpayment": 75000000,
    "contractliabilitytransferredtorevenue": 75676000,
    "contractliabilityexchangerealignment": 6702000,
    "deferredtaxexpenseincome": -33050000,
    "deferredtaxcarryforwardperiod": "P9Y",
    "deferredtaxcarrybackperiod": "P1Y",
    "withholdingtaxpercentage": 0.3,
    "deductibletemporarydifferencesforwhichnodeferredtaxassetisrecognised": 74409000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 144099000,
    "governmentgrants": 2334000,
    "authorizedsharecapital": 50000,
    "numberofsharesauthorised": 500000000,
    "numberofsharesissuedandfullypaid": 266010256,
    "sharecapitalandsharepremiumnumberofsharesinissue": 266010256,
    "issuanceofordinarysharesforconversionofpreferredsharesnumberofsharesinissue": 20907282,
    "issuanceofordinarysharesforinitialpublicofferingnetofissuancecostnumberofsharesinissue": 42377500,
    "issuanceofordinarysharesforprivateplacementnumberofsharesinissue": 1043478,
    "exerciseofshareoptionnumberofsharesinissue": 1681996,
    "sharecapitalandsharepremium": 708333000,
    "issuanceofordinarysharesforconversionofpreferredshares": 240434000,
    "issuanceofordinarysharesforinitialpublicofferingnetofissuancecost": 450085000,
    "issuanceofordinarysharesforprivateplacement": 12000000,
    "exerciseofshareoption": 1886000,
    "dateofgrantofsharebasedpaymentarrangement": "December 21, 2017",
    "periodofshareoptionschemeremaininforce": "P10Y",
    "weightedaverageexercisepriceofshareoptionsinsharebasedpaymentarrangementexercisedduringperiodatdateofexercise2019": 14.9131,
    "weightedaveragefairvalueatmeasurementdateshareoptionsgranted": 6666000,
    "weightedaveragesharepriceshareoptionsgranted2019": 15.364,
    "expensesrecognizedforshareoptions": 1905000,
    "weightedaveragesharepriceusedinshareoptionfairvalue": 15.6128,
    "numberofoutstandingshareoptions": 14241000,
    "additionalsharecapitalamount": 1424,
    "sharepremiumbeforeissueexpenses": 23122000,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 1.9353,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 15.6128,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 0.9963,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 1.0131,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 1.0703,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 679,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 2769,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 1682,
    "numberofshareoptionsexercisableinsharebasedpaymentarrangement": 4619,
    "exercisepriceofoutstandingshareoptions2019": 11.5,
    "shareoptionsexerciseperiod": "2030-11-18",
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.872,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0091,
    "descriptionofoptionlifeshareoptionsgranted": 10,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P8Y10M2D",
    "weightedaveragefairvalueatmeasurementdateotherequityinstrumentsgranted": 17497000,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 1113000,
    "numberofinstrumentsotherequityinstrumentsgranted": 1139000,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 26000,
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement2019": 15.3409,
    "weightedaverageexercisepriceofotherequityinstrumentsgrantedinsharebasedpaymentarrangement2019": 15.3639,
    "weightedaverageexercisepriceofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement2019": 16.335,
    "netassetsliabilities": 26000000,
    "noncashadditionstorightofuseassets": 491000,
    "noncashadditionstoleaseliabilities": 491000,
    "noncashadditionstofinancecosts": 1500000,
    "noncashotherpayable": 1500000,
    "liabilitiesarisingfromfinancingactivities": 3373000,
    "increasethroughnewleasesliabilitiesarisingfromfinancingactivities": -437000,
    "increasedecreasethroughfinancingcashflowsliabilitiesarisingfromfinancingactivities": -2602000,
    "increasedecreaseininterestexpense": 195000,
    "interestpaidclassifiedasoperatingactivities": 195000,
    "fairvaluelossofconvertibleredeemablepreferredsharevalue": 79984000,
    "increasedecreaseofconversiontoordinaryshares": 240434000,
    "cashoutflowforleaseswithinoperatingactivities": 195000,
    "cashoutflowforleaseswithinfinancingactivities": 2602000,
    "cashoutflowforshorttermleases": 69000,
    "constructioninprogress": 33637000,
    "descriptionofnatureofrelatedpartyrelationship": "Company controlled by the ultimate holding company",
    "purchasesofgoodsrelatedpartytransactions": 4634000,
    "managementfeerelatedpartytransactions": 154000,
    "purchasesofpropertyandotherassetsrelatedpartytransactions": 54000,
    "servicesreceivedrelatedpartytransactions": 3298000,
    "leaseterm": "P12M",
    "lesseesincrementalborrowingrateappliedtoleaseliabilities": 0.0728,
    "leaseliabilitiesrepaymentterm": "P5Y",
    "amountspayablerelatedpartytransactions": 933000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 1733000,
    "keymanagementpersonnelcompensationsharebasedpayment": 529000,
    "keymanagementpersonnelcompensationterminationbenefits": 774000,
    "keymanagementpersonnelcompensation": 3036000,
    "financialassetsatamortisedcost": 581395000,
    "financialliabilitiesatamortisedcost": 94170000,
    "percentageofforeigncurrencyforwardexchangecontract": 0.15,
    "percentageofincreasedecreaseinrateofforeigncurrency": -0.05,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 817000,
    "tradeandotherpayables": 5238000,
    "financialliabilities": 94360000,
    "capitalgearingratio": 0.61
  }
]